Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy

Most currently recommended therapies for metabolic dysfunction-associated fatty liver disease (MAFLD) involve diet control and exercise therapy. We searched PubMed and compiled the most recent research into possible forms of programmed cell death in MAFLD, including apoptosis, necroptosis, autophagy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jianan, Hu, Yiyang, Peng, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103580/
https://www.ncbi.nlm.nih.gov/pubmed/33962586
http://dx.doi.org/10.1186/s11658-021-00254-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103580/
https://www.ncbi.nlm.nih.gov/pubmed/33962586
http://dx.doi.org/10.1186/s11658-021-00254-z

Ejemplares similares